SHROOM4 and lung carcinoma: Collectively, the survival probability of lung cancer patients with high-level of SHROOM4 was significantly longer than those with low-level SHROOM4, indicating high mRNA expression of SHROOM4 is a biomarker of positive prognosis in lung cancer.